Who owns Melano CC?
Melano CC is owned by Rohto Pharmaceutical (Japan, TSE: 4527).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: ROHTO Well-being Report 2025 (Rohto Pharmaceutical Integrated Report 2025), ROHTO Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- ROHTO Pharmaceutical Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Osaka
- Origin
- 🇯🇵 Japan
- Category
- Personal care & beauty › Skin care › Facial skin care
- Parent ticker
- TSE: 4527
- Last verified
- · 2 sources
About Melano CC
Melano CC is a Rohto Pharmaceutical skincare line built around vitamin C. Most of the range is sold in Japan as quasi-drugs to prevent dark spots, freckles and acne: a concentrated spot serum and a premium version of it, lotions, a mist, an emulsion, a gel and a cream. Alongside them it sells sheet masks, an enzyme face wash, an SPF50+ UV milk, slow-release vitamin C tablets and a Melano CC Men line. Rohto names it with Obagi and Hada Labo as a core brand it means to strengthen.
Ownership timeline of Melano CC
- Current owner Rohto Pharmaceutical [1] reported
Where Melano CC sits in Rohto Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Rohto Pharmaceutical ownership tree →
See the full Rohto Pharmaceutical brand portfolio (4) →
Other brands owned by Rohto Pharmaceutical
Rohto Pharmaceutical controls 4 brands on Brandtree, 3 of them in personal care & beauty.
Also in personal care & beauty
Other brands in facial skin care, and who owns them
The 76 brands in facial skin care on Brandtree belong to 38 owners. The largest is POLA ORBIS, with 6; Rohto Pharmaceutical has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| DECENCIA | POLA ORBIS | 🇯🇵 Japan |
| Clinique | Estée Lauder | 🇺🇸 United States |
| ANYA | Proya | 🇨🇳 China |
| COSRX | Amorepacific | 🇰🇷 South Korea |
| Clé de Peau Beauté | Shiseido | 🇯🇵 Japan |
| Paula's Choice | Unilever | 🇬🇧 United Kingdom |
| ALBION | KOSÉ | 🇯🇵 Japan |
| O HUI | LG H&H | 🇰🇷 South Korea |
About the owner: Rohto Pharmaceutical
Rohto Pharmaceutical is a publicly listed company headquartered in Osaka, Japan, founded in 1899. Brandtree records 4 brands under its control, and it is listed as TSE: 4527.
Rohto Pharmaceutical is an Osaka company founded on 22 February 1899 to sell Ikatsu, a stomach medicine. It launched Rohto Eye Drops in 1909 and holds the largest share of Japan's over-the-counter eye care market. It moved into skincare in 1975 with the Mentholatum range and in 1988 bought the American company that owns that name, The Mentholatum Company, through which it now sells in much of the world; about 40 per cent of its sales are made outside Japan. Its skincare brands include Hada Labo, Melano CC and Skin Aqua, and in 2025 it acquired the Obagi trademarks for Japan, where it had sold that brand since 2001. In the year to March 2026 it had consolidated sales of ¥343.7 billion and 9,292 employees. It is listed on the Prime Market of the Tokyo Stock Exchange.
Rohto Pharmaceutical: full profile, brands and acquisition history →
🇯🇵 Melano CC and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Melano CC is not one of them.
Frequently asked questions
Who is the parent company of Melano CC?
The parent company of Melano CC is Rohto Pharmaceutical, a publicly listed company headquartered in Japan.
Is Melano CC Japanese?
Yes. Melano CC originated in Japan and its owner, Rohto Pharmaceutical, is also headquartered in Japan.
Is Melano CC still owned by Rohto Pharmaceutical?
Yes. As of 2 October 2026, Melano CC is still owned by Rohto Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] ROHTO Well-being Report 2025 (Rohto Pharmaceutical Integrated Report 2025) — ROHTO Pharmaceutical Co., Ltd., Annual report; retrieved 2 October 2026.
- [2] ロート製薬 — メラノCC — ROHTO Pharmaceutical Co., Ltd., Official document; retrieved 2 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.